Eveline Jona
Clayton, VIC 3168, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Early pregnancy biomarkers of inflammation and metabolic regulation in polycystic ovary syndrome.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 27, 2025
Prolactin in high-metabolic risk pregnancies: Associations with maternal obesity and metabolic health.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: November 27, 2025
Lipidomic profiling reveals a distinct lipidomic signature of early gestational diabetes.
Journal: Communications medicine
Published: October 07, 2025
Metabolic associations of human placental lactogen in pregnancies at high metabolic risk: An observational cohort study.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: February 26, 2025
Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial.
Journal: BMC endocrine disorders
Published: May 05, 2020
Brown adipose tissue thermogenesis in polycystic ovary syndrome.
Journal: Clinical endocrinology
Published: September 18, 2018
Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome-A Randomized Controlled Trial.
Journal: Frontiers in physiology
Published: March 27, 2018
Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance.
Journal: Clinical endocrinology
Published: March 11, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026